Alnylam Pharmaceuticals (NASDAQ:ALNY) Given Neutral Rating at Cantor Fitzgerald
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “neutral” rating restated by equities researchers at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They presently have a $165.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 6.63% from the stock’s previous close. […]
More Stories
Meta Platforms, Inc. (NASDAQ:META) Shares Acquired by Brown Lisle Cummings Inc.
Brown Lisle Cummings Inc. boosted its holdings in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 8.1% in the first...
Spinnaker Investment Group LLC Has $582,000 Position in Meta Platforms, Inc. (NASDAQ:META)
Spinnaker Investment Group LLC raised its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 41.7% during...
The J. M. Smucker Company (NYSE:SJM) Shares Sold by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund trimmed its stake in shares of The J. M. Smucker Company (NYSE:SJM – Free...
Food Independence Summit Teaches a Return to Self-Sufficient Roots
By Jeff Louderback WALNUT CREEK, Ohio—Decades ago, many Americans knew the origin of their food. They lived in rural areas,...
Meta Platforms, Inc. (NASDAQ:META) is Oppenheimer & Co. Inc.’s 6th Largest Position
Oppenheimer & Co. Inc. raised its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 2.7% during...
AutoZone, Inc. (NYSE:AZO) SVP Sells $2,697,847.50 in Stock
AutoZone, Inc. (NYSE:AZO – Get Free Report) SVP K. Michelle Borninkhof sold 750 shares of the business’s stock in a...